Form 4: RxSight COO Receives Stock Grant
Insider Transaction (Form 4)
Ilya Goldshleger, Chief Operating Officer of RxSight, Inc., reported multiple transactions in common stock on September 5, 2026.
Summary
- Disposition to the issuer: disposed of 98,367 Stock option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 120,000 Stock Option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 92,200 Stock Option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 50,000 Stock Option (right to buy) on September 5, 2026 (Direct).
- Disposition to the issuer: disposed of 125,000 Stock Option (right to buy) on September 5, 2026 (Direct).
- Grant/award: acquired 73,960 Stock Option (right to buy) on September 5, 2026; holds 73,960 after (Direct).
- Grant/award: acquired 104,347 Stock Option (right to buy) on September 5, 2026; holds 104,347 after (Direct).
- Grant/award: acquired 59,483 Stock Option (right to buy) on September 5, 2026; holds 59,483 after (Direct).
- Grant/award: acquired 32,258 Stock Option (right to buy) on September 5, 2026; holds 32,258 after (Direct).
- Grant/award: acquired 93,984 Stock Option (right to buy) on September 5, 2026; holds 93,984 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ilya Goldshleger — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-05 | Disposition to the issuer | Stock option (right to buy) | 98,367 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 120,000 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 92,200 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 50,000 | — | — | 0 |
| 2026-09-05 | Disposition to the issuer | Stock Option (right to buy) | 125,000 | — | — | 0 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 73,960 | — | — | 73,960 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 104,347 | — | — | 104,347 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 59,483 | — | — | 59,483 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 32,258 | — | — | 32,258 |
| 2026-09-05 | Grant/award | Stock Option (right to buy) | 93,984 | — | — | 93,984 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-05 | Disposition to the issuer (98,367 shares) |
| 2026-09-05 | Disposition to the issuer (120,000 shares) |
| 2026-09-05 | Disposition to the issuer (92,200 shares) |
| 2026-09-05 | Disposition to the issuer (50,000 shares) |
| 2026-09-05 | Disposition to the issuer (125,000 shares) |
| 2026-09-05 | Grant/award (73,960 shares) |
| 2026-09-05 | Grant/award (104,347 shares) |
| 2026-09-05 | Grant/award (59,483 shares) |
| 2026-09-05 | Grant/award (32,258 shares) |
| 2026-09-05 | Grant/award (93,984 shares) |
Keywords
insider transaction, Form 4, RXST, RxSight, Inc., neutral, Ilya Goldshleger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.